In TCGA-BLCA dataset, UBC patients with higher mRNA expression level of GFPT2 and PGM3 had significantly shorter OS time, while UBC patients with higher GFPT2, GNPNAT1, and PGM3 mRNA levels had significantly shorter DFS duration (Figure 2A). This evidence concerns the gene GFPT2 and bladder transitional cell carcinoma.